Clinical use in COVID-19
In COVID-19 patients, the use of glucocorticoids (GCs) is rather controversial (172,173). Early-start of GCs could be helpful for patients who have an overly exuberant inflammatory response or are at high risk of developing ARDS, whereas the benefit of GCs as rescue treatment remains doubtful (174).